Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara

Go back to Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara
(NASDAQ: CODX) Delayed: 1.52 +0.10 (7.04%)
Previous Close $1.42    52 Week High
Open $1.45    52 Week Low
Day High $1.54    P/E N/A 
Day Low $1.39    EPS
Volume 249,347